NCT04555915View on ClinicalTrials.gov

General Movement Assessment - Ancillary Study to SafeBoosC III Trial

CompletedOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions
General Movement Assessment
Interventions
OTHER

Monitoring of cerebral oxygenation

Modify cardio-respiratory support to avoid cerebral hypoxia

Trial Locations (1)

8036

Dep. of Pediatrics, Medical University of Graz, Graz

All Listed Sponsors
collaborator

Rigshospitalet, Denmark

OTHER

lead

Medical University of Graz

OTHER

NCT04555915 - General Movement Assessment - Ancillary Study to SafeBoosC III Trial | Biotech Hunter | Biotech Hunter